Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interim analysis in clinical trials.

P Armitage1

  • 1Department of Statistics, University of Oxford, U.K.

Statistics in Medicine
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Data monitoring committees (DMCs) are crucial for clinical trials, reviewing data for safety and efficacy. They advise investigators on early trial termination or protocol changes based on statistical assessments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trial analysis by treatment allocated or by treatment received? Origins of 'the intention-to-treat principle' to reduce allocation bias: Part 2.

Journal of the Royal Society of Medicine·2023
Same author

Trial analysis by treatment allocated or by treatment received? Origins of 'the intention-to-treat principle' to reduce allocation bias: Part 1.

Journal of the Royal Society of Medicine·2023
Same author

The Profiles and Correlates of Psychopathology in Adolescents and Adults with Williams, Fragile X and Prader-Willi Syndromes.

Journal of autism and developmental disorders·2019
Same author

The assessment of fetal brain growth in diabetic pregnancy using in utero magnetic resonance imaging.

Clinical radiology·2017
Same author

Surface reconstructions of foetal brain abnormalities using ultrafast steady state 3D acquisitions.

Clinical radiology·2014
Same author

Studies on the transmission of cotton rat filariasis; factors influencing the efficiency of the vector, Liponyssus bacoti.

Annals of tropical medicine and parasitology·2014
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Medical Research Methodology

Background:

  • Historically, experimental design discouraged sequential data analysis, yet it's a natural scientific inquiry.
  • Clinical investigators require continuous technique monitoring and often delegate data oversight to independent groups.
  • Data Monitoring Committees (DMCs) play a vital role in ensuring trial integrity and patient safety.

Purpose of the Study:

  • To review the history and functions of Data Monitoring Committees (DMCs).
  • To explore statistical approaches for early trial termination decisions.
  • To critically examine methods for assessing treatment effects and trial outcomes.

Main Methods:

  • Review of historical development and functional roles of DMCs.

Related Experiment Videos

  • Analysis of statistical methodologies for early stopping, including group sequential analyses.
  • Examination of two primary approaches to early stopping: critical value demonstration and stochastic curtailment.

    • Main Results:

    • DMCs are diverse in structure and function, requiring comprehensive data review.
    • Statistical considerations for DMCs include data management, safety, and efficacy assessments.
    • Two main early stopping strategies exist: demonstrating strong evidence or using stochastic curtailment, with the latter critically examined.

    Conclusions:

    • DMCs provide essential independent oversight for clinical trials.
    • Statistical methods, including group sequential analyses, are integral to DMC recommendations.
    • While established methods exist, challenges remain in data interpretation and decision-making for early trial termination.